1. Introduction {#s0005}
===============

Caffeic acid (CA) (3,4-dihydroxycinnamic acid) is one of the most widely distributed hydroxycinnamate and phenylpropanoid metabolites, being thus a polyphenol that can be found in many dietary sources of plant origin, including coffee drinks, blueberries, apples, and cider ([@b0035]). In addition to the notorious antioxidant potency of CA, *in vitro* studies demonstrated the antimicrobial action of propolis against different pathogenic microorganisms of the mouth ([@b0060], [@b0085], [@b0100]). It is also known as a carcinogenic inhibitor ([@b0050], [@b0125]) and can contribute to the prevention of atherosclerosis and other cardiovascular diseases ([@b0150], [@b0155], [@b0075]).

Acne is the most common among skin diseases and the following etiopathogenic factors are prominent: sebum production by the sebaceous glands, follicular hyperkeratinization, release of inflammatory mediators in the follicle and adjacent dermis and bacterial colonization of the follicle ([@b0010]).

The three major microorganisms isolated from the skin surface and sebaceous gland ducts of individuals with acne are *Propionibacterium acnes*, *Staphylococcus epidermidis* and *Malassezia furfur*, the first being certainly the most importante ([@b0010]). *P. acnes* is a gram-positive, anaerobic bacillus that is involved in the inflammatory response of the pathogenesis of acne ([@b0095]). It is predominant in the sebaceous region of the skin, located in the hair follicle, being transported to the surface of the skin by the sebaceous flow. It metabolizes fractions of sebaceous triglycerides and occurs more in adolescence, being rare in childhood. It is not an infectious bacterium, but it is one of the main factors in the development of acne ([@b0080]).

For many years, antibiotic therapy has been a form of treatment, however, the adverse reactions caused by the medications end up making the treatment unpleasant, in addition to reported cases of decreased sensitivity to antibiotics ([@b0095]). The topical drugs class include retinoids ([@b0120]), benzoyl peroxide, antibiotics, alpha-hydroxyacids, azelaic and salicylic acids and corticosteroids, and systemic treatment consists of oral antibiotics ([@b0010]).

The use of natural products in dermatology is becoming increasingly common due to the increased resistance of bacteria to synthetic antibiotics and the active principles of medicinal plants become a new option as antiseptics and antimicrobials ([@b0095]). Several propolis components were analyzed in different countries, with CA, phenolic esters of CA and flavonoids responsible for the antibiotic power of this resin. The antimicrobial activity of some active substances is widely explored in the cosmetic segment in the form of products with various purposes ([@b0010]). It is believed that compounds such as flavonoids, CA, benzoic acid, cinnamic acid, appear to act on the membrane or cell wall of the microorganism, causing functional and structural damage. From these data, it is suggested to formulate less aggressive cosmetic formulations, but to provide the efficacy of drugs frequently used for acne ([@b0095]).

Acne treatment is primarily aimed at minimizing the physical and aesthetic discomforts of acne inflammations, preventing and reducing marks and scars which can lead, depending on the intensity, psychological, emotional and social damages ([@b0080]).

In the past, the trans-follicular route was only a secondary route of transdermal penetration ([@b0065]). However, in the decade of the 90′s, it was demonstrated that percutaneous penetration of several drugs was greater in hairy mice compared to hairless mice ([@b0140]).

Advances in nanotechnology have opened new opportunities for the delivery of molecules to the hair follicle (HF) as they can accumulate into these structures releasing drugs for an extended period, since both hydrophilic and lipophilic compounds can be incorporated in these delivery systems ([@b0045]). As HF represents an invagination, or extension, of the epidermis, it offers an increased available surface area, much greater than initially assumed. In addition, this epidermis is much thinner and the region is surrounded by numerous blood capillaries and immunocompetent cells, which contributes to drug absorption and / or the production of an immune response ([@b0070], [@b0090]). In 2006, [@b0070] also found that HF act as a long-term reservoir of these particles for up to 10 days. This finding means that, after accumulation on the HF the drugs can be released over time and continuously diffused into the surrounding follicular and perifollicular cells or through the capillary walls to reach the bloodstream. Targeted delivery of medications through HF can become very advantageous as it covers a wide range of different applications ranging from cosmetic products for acne treatment to non-invasive transcutaneous vaccination, including treating cutaneous disorders such as atopic dermatitis, folliculitis and even psoriasis ([@b0105], [@b0070]). For this work, microparticles (MPs) containing CA have been designed for the treatment of folliculitis and incorporated into a semisolid formulation to facilitate its topical application. In this case, oil/water (o/w)-emulsions were selected to formulate both, the MPs and free CA as a control. Emulsions present several advantages over other semisolid formulations, such as an easy scattering, possible penetration enhancement, protection against unstable compounds, tunable release of drugs and absorption, with the consequently modulation in the activity of the incorporated drugs ([@b0130]).

Taking into account the characteristics of the skin and the demonstrated antimicrobial efficacy of CA, drug distribution studies within the different skin layers and structures of this drug are of great interest. In the present work, we perform these studies through the techniques of tape stripping and differential stripping of CA incorporated in MPs.

The tape stripping technique is widely used and accepted to study the kinetics and penetration of active substances in the skin, allowing to determine the location and distribution of substances in the stratum corneum (SC). Especially in the last decades, it has become one of the main investigative techniques used in studies of topical bioavailability and bioequivalence, being proposed by the FDA in 1998 ([@b0115], [@b0030], [@b0015], [@b0040], [@b0025]). The method of evaluation of cutaneous penetration can be performed in two ways*, in vitro* or *in vivo*. The *in vitro* method has a number of advantages over *in vivo*, since they can be used on human skin or on other species skins, many replicates can be made, there is no use of live animals, thus avoiding ethical and still several pharmaceutical forms can be studied. The limitation attached to the *in vitro* approach is that the sink conditions generated by the blood flow in the dermis are not fully reproduced ([@b0145]).

The Differential Stripping method is the most straightforward technique to determine follicular uptake quantitatively. For this study, pig ear skin is used because it has been evaluated as a valuable *in vitro* model, being known as the "gold standard" since it is considered superior to human skin because HFs in the human skin contract immediately after excision, whereas the cartilage in the porcine skin prevents the contraction of the traction fibers and, therefore, the subsequent closure of the HFs. Anatomically, the HFs of human and porcine are similar in several aspects, such as SC density and follicular diameter. Thus, the pig ear is attributed to this type of study and only ears with immaculate skin surface (no abrasions, inflammation, etc.) should be used ([@b0070]). The term 'Differential Stripping' was first introduced in 2005 by Teichmann et al., and described the combination of the tape stripping technique with cyanoacrylate skin surface biopsies (removing the follicular cast). However, the method was rather a qualitative analysis than a quantitative way of determining follicular penetration. In 2014, Raber et al. modified and optimized this method, and ultimately obtained a protocol which made it feasible to fully quantify follicular uptake of particles ([@b0070]).

In this study, we develop two emulsion types, one containing free CA dispersed in the oil phase of the emulsion and incorporated in MPs, as a sustained release delivery system to target the hair follicles. Drug distribution studies were performed by the two avobe mentioned techniques in human and porcine skin respectively to demonstrate that the formulated particles do improve the drug accumulation into the target tissue, which is the hair follicle.

2. Material and methods {#s0010}
=======================

2.1. Materials {#s0015}
--------------

Skin samples: abdominal human skin samples obtained from surgical corrections after previously signed informed consent by the patients at the Wuiron Clinic, Valencia. Porcine skin was obtained from the Scientific Support Center for Research of the University of Valencia. The use of animal and human tissue was approved by the Research Ethics Committee of the Universitat de Valencia, Spain under the Protocol number: H1462978691586 and the sample obtention and further treatment followed the current European Law; Chemicals: Tesafilm® kristall-klar (Tesa, 33 m × 19 mm, cut to 30 × 19 mm sections) was obtained from Tesa AG, Hamburg, Germany; UHU superglue (UHU, blitzschnell Pipette) was kindly provided by UHU GmbH & Co, KG, Bühl/Baden, Germany; Parafilm Sealing Film − 50 mm (2″) Film Width × Roll Length 75 m (Madrid/Spain); Glass Beads (MERCK® - Madrid/Spain); Composition of the mobile phase: distilled water, methanol grade CLAE (MERCK® - Madrid/Spain), Acetic acid (MERCK® - Madrid/Spain); Composition of the emulsion: Cetearyl Alcohol and Sodium Cetearyl Sulfate (Mapric® - Brasil), Glyceryl Stearate (CUTINA® GMS V - BASF® - Brasil), Ethylhexyl Stearate (BASF® - Brasil), Glycerin (Mapric®), EDTA Na~2~ (Brasquim®)~,~ Cafeic acid (Nanjing Zelang Medical Technology); Microparticles composition: Cafeic acid (Nanjing Zelang Medical Technology), Chitosan medium molecular weight (Sigma Aldrich®- Brasil); Acetic acid (Synth - Brasil); polysorbate 80 (Synth -- Brasil).

2.2. Methods {#s0020}
------------

### 2.2.1. Preparation of formulations containing CA {#s0025}

Emulsions containing CA were prepared at laboratory scale, one of which contain free CA and the other microencapsulated CA. Their composition is described in [Table 1](#t0005){ref-type="table"}. The MPs are composed of 10% CA and were obtained by spray drying technique as described by [@b0145]. A dispersion of chitosan with medium molecular weight (Sigma- Aldrich!) was prepared at 0.5% (w/v) in 1% (v/v) acetic acid. To this dispersion, a mass of CA equivalent to 30% of the chitosan dry weight and 1% of polysorbate 80 was added for CA solubilization in the dispersion. The dispersion of chitosan \[0.5% (w/v)\] with CA was atomized in BUCHI-290 Mini Spray Dryer. The following parameters were programmed into the equipment: air inlet temperature, 180 °C; pump flow, 10%; atomizing air flow, 450 NL/h; aspirator efficiency, 90%; and air outlet temperature, 80 °C. ([@b0145]).Table 1Composition of the emulsion.Emulsion with free CAEmulsion with microparticles of CAInci Name%Inci Name%Cetearyl Alcohol8.0Cetearyl Alcohol8.0Sodium Cetearyl Sulfate1.5Sodium Cetearyl Sulfate1.5Glyceryl Stearate1.0Glyceryl Stearate1.0Ethylhexyl Stearate3.0Ethylhexyl Stearate3.0Glycerin3.0Glycerin3.0EDTA Na~2~0.1EDTA Na~2~0.1Waterq.s.p. 100Waterq.s.p. 100Free CA0.5Microparticles with CA5.0

### 2.2.2. Tape stripping {#s0030}

The assay was performed using abdominal human skin samples obtained from surgical corrections by approval of the Research Ethics Committee of the Universitat de Valencia, Spain under the Protocol number: H1462978691586. Excess fat and connective tissues were removed, and the samples stored in a freezer at −26 °C for less than three months. The skin was placed on a glass blade with the outside facing upwards and an aluminum mold was placed over it, leaving the application area uncovered. Two tests were performed. In the first one, the formulation containing free CA was applied to delimited area of skin and in the second, the formulation containing the CA encapsulated in the MP, both in the concentration of 0.5% CA. Thereafter, the system was incubated at 32 °C for two hours. Each test was performed in triplicate. (see [Fig. 1](#f0005){ref-type="fig"}).Fig. 1Schematic Incubation, tape-stripping technique and differential-stripping technique.

The technique is characterized by being minimally invasive in which the SC is removed after sequential applications of adhesive tapes, allowing the quantification of active present in the first layer of the skin ([@b0115], [@b0030]). The removed tape strips contain not only information about the amount of corneocytes and the penetrated substances but also about the distribution of the substances in the different depths of the SC ([@b0005]).

Tape stripping experiments are relatively easy and simple to perform; however intrinsic or extrinsic parameters may influence the amount of active and SC removed by the tape. It is generally assumed that 10 to 20 adhesive tapes are required for complete removal of the SC and that the first 10 tapes may exhibit 90% of the concentration of the active present in that layer, so that the subsequent tapes contribute in less of 5% ([@b0115], [@b0015], [@b0025]).

Variability is avoided by performing replicates using skins from the same donor. The CA present in each sample is extracted from the strips by the use of an acidified ethanol: water (40: 60, v/v) extractive solution under stirring for a period of 24 h and subsequently quantified by HPLC through the method validated by [@b0135]. A mass balance study was previously done extracting all samples, the rest of the skin and all materials in touch with the formulation, to assure the complete extraction of CA by this method. A recovery of 93.7 ± 2.34 was obtained. The tape-stripping data represent the drug distribution within the SC and gives an insight into the concentration gradient of CA through this layer, which is the limiting barrier for drug diffusion. The experiments were performed in triplicate.

### 2.2.3. Differential stripping {#s0035}

In order to analyze the extent of active penetration into the hair follicle, the differential tape stripping technique is used in the external auricle of porcine ear skin. The first step of this protocol entails applying the formulation onto a predetermined area on the outer side of auricle pig ear. After a predetermined incubation time under constant temperature conditions, subsequent tape strips are taken in order to clean the skin surface and remove the SC layer by layer like described in [Section 2.2.2](#s0030){ref-type="sec"}. (see [Fig. 1](#f0005){ref-type="fig"}).

To analyze the extent of follicular drug penetration, cyanoacrylate skin surface stripping is performed. This step implies the application of superglue to the pretreated skin area covered by a tape strip. Upon polymerization of the glue, the tape strip is quickly peeled off, removing the entire follicular cast.

For quantification and mass-balance purposes the substance of interest is extracted from the tape strips, cyanoacrylate biopsies, as well as all application devices, and skin rest are analyzed for drug content via an analytical method of choice ([@b0070]).. The experiments were performed in triplicate.

3. Results and discussion {#s0040}
=========================

3.1. Tape stripping {#s0045}
-------------------

The first strip is usually discarded, as n the surface of the skin there is an excess of formulation that is difficult to be completely clean without damaging the surface. This is the case in the present work and because of that (S1) was discarded.

Tape S2 shows a decrease in the total amount of CA extracted from the sample. Samples S3-S5 and S6-S10 show a higher total amount of sample, but it should be taken into account that this samples are the summatory of three strips. The strips had to be collected and extracted in groups because the amount of drug present in each strip is low and after dilution in the extraction medium, the concentration is too close to the detection limit to assure a reliable quantification.

Samples S11-15 and S16-20 show a decrease in the amount of quantified CA, as it was expected. Thus, it can be seen that the amount of active decreases while the SC depth increases.

The average amount of CA found in each tape when the tape stripping was performed with the emulsion containing free CA was: tape 1 = 3.877 µg; tape 2 = 1.79 µg; tapes 3--5 = 3.13 µg; tapes 6--10 = 5.04 µg; tapes 11--15 = 1.78 µg; tapes 16--20 = 1.03 µg. The amount of CA in the dermis and epidermis was also founded: 47.60 µg. The average amount of CA found in each tape when the tape stripping was performed with the emulsion containing CA-MPs was: tape 1 = 2.56 µg; tape 2 = 1.76 µg; tapes 3--5 = 2.39 µg; tapes 6--10 = 2.01 µg; tapes 11--15 = 1.32 µg; tapes 16--20 = 1.13 µg. The amount of CA (µg) in the dermis and epidermis was also founded: 2.88 µg.

These results are presented in [Fig. 2](#f0010){ref-type="fig"}. A comparative analysis between the studies performed with free and microparticulate CA, shows that the amount of active when incorporated in the MP is lower. However, there is a smaller variation of values between the tapes, what indicates a more homogeneous distribution of CA within the SC. The amounts of CA (µg) present in the SC formulated as a free CA emulsion vary between 1.03 and 5.04 µg, what clearly show significant oscillations compared to CA formulated in the emulsion containing MP (1.13 to 2.56 µg) (ANOVA, p = 0.5). This fact shows a better control not only in drug release but also in drug distribution within the tissue.Fig. 2Representative graph of the amounts of AC present in each layer of the stratum corneum and epidermis and dermis. a. Tape Stripping with emulsion with CA free; b. Tape Stripping with emulsion with microparticles of CA.

Although a higher amount of CA in the epidermis dermis was recovered when CA was not encapsulated, what was expected because the free drug is more readily bioavailable. CA-MPs, are drug delivery systems, which can be more retained on the SC releasing the drug in a controlled and prolonged way the active in the deeper layers of the skin. Thus, the release of CA contained in the MP, under the same conditions as an emulsion with free CA, leaves the SC towards the epidermis dermis.

3.2. Differential stripping {#s0050}
---------------------------

The present study showed a tendency of greater retention of the MPs in the hair follicle when compared to the study done with the free CA, since the amount of CA found in the follicle in the study with MPs is larger ([Fig. 3](#f0015){ref-type="fig"}).Fig. 3Representative graph of the amounts of CA present in the follicle (Sum of the quantity of CA found in follicles in differential stripping) and epidermis and dermis of pig ear skin.

The total amount of CA found in follicles when the differential stripping was performed, in triplicate. The values obtained from the emulsion containing free CA were: Follicle 1 = 0.84 µg; follicle 2 = 1.13 µg; follicle 3 = 1.15 µg. The amount of CA in the dermis and epidermis was: Epidermis and Dermis 1 = 9.57 µg; epidermis and dermis 2 = 15.55 µg; epidermis and dermis 3 = 9.20 µg.

The total amount of CA found in follicles when the differential stripping was performed, in triplicate, with the emulsion containing MP-CA was: Follicle 1 = 1.76 µg; follicle 2 = 1.72 µg; follicle 3 = 1.57 µg. The amount of CA in the dermis and epidermis was also founded: Epidermis and Dermis 1 = non-detectable amounts; epidermis and dermis 2 = 1.42 µg; epidermis and dermis 3 = 1.58 µg.

These results are presented in [Fig. 3](#f0015){ref-type="fig"}.

Follicular penetration is an important and promising pathway for dermatotherapy. Innovative cosmetic formulations are developed to optimize the penetration and storage of topically applied molecules. These approaches focus primarily on nano or micro technology. In order to observe the follicular penetration, it is interesting to carry out retention studies with formulations of emulsion type, since their higher viscosity allow the accumulation of is the MPs containing the drug inside the follicle. In the case of solutions, what are the most studied samples concerning follicular penetration, an easy entrance and exit of the follicle would be expected, rather than retention, as desired.

Considering the results obtained, the MP penetration efficacy is higher compared to the free CA formulation, as expected. About the greater tendency of retention in the hair follicle when the CA is incorporated into MP, it can be seen in [Fig. 3](#f0015){ref-type="fig"} that the amounts of CA retained in the follicle from the MP emulsion is 1.68 ± 0.07 and from the emulsion containing free CA 1.04 ± 0.13. Through ANOVA analysis of variance a statistically significant difference between the values, considering the value of p \< 0.05, was found.

According to previous works, the ability of micro and nanoparticles to accumulate into the hair follicles is mainly determined by their size ([@b0110]). That is why the particles of this work were already designed with the optimal size, according to the morphology studies using photomicrographs obtained by scanning electron microscopy performed by [@b0145]. In these studies, the samples were covered with a thin layer of gold photomicrographed at 10.000× magnification with an electron beam of 2.0 kV using the high-resolution scanning electron microscope S-4800 (Serial Number: HI-9269-0009) and it was found that the diameter of MP ranged from 1 to 5 µm and they are spherical and had a smooth surface, which is ideal for controlled release. Therefore, we demonstrate through this work that the designed MPs are suitable to target the hair follicle for the treatment of folliculitis. In addition, these structures offer the advantage over the free CA-emulsion, of guaranteeing a constant release of drug in these structures, allowing the reduction of applications, as it can be assumed that the drug will be released over the whole hair regeneration period, which is of about 15 days ([@b0070]). The previous permeation studies showed that the MP used have a flow of J = 0.92 ± 0.24 mg/cm^2^/h and a lag time of T = 4.04 ± 0.28, which shows that, the emulsion containing MP, in addition to promoting a slower flow of AC, also took longer to begin to permeate. Therefore, as CA is retained in the MP formulation in a more efficient manner, thus, it can also be expected that the permeation profile is also more controlled ([@b0145]). It was also demonstrated increased lag time and a reduction in the CA flux in the emulsion systems. This can be explained by the viscosity of the systems proving that viscosity is one of the factors that affect the flow of the permeant ([@b0020]). The drug in MP will therefore stay in contact with the skin, for a longer time, thus improving its antimicrobial directly on the target site, as desired when designing the formulation ([@b0145]).

Previous drug release works demonstrated that the percentages of CA release after 30 min from an emulsion containing 0.5% active ingredient was high compared to the same formulation observed over 2 h but containing 1% encapsulated CA. Furthermore, the emulsion containing 0.5% CA showed only a small change after the 4 h evaluation, meaning that the dose was depleted ([@b0045]). On the contrary, after the same time, the encapsulated CA-emulsion had still not reached an asimpthote.

Besides, the hair follicles present a thinner SC, thus facilitating the drug access to the infected area and to the epidermis beneath, offering the possibility to treat conditions affecting the area below the hair follicle as well.

4. Conclusions {#s0055}
==============

From the present work it can be concluded that MPs deliver CA providing a more homogeneous distribution through the SC and are more retained in the hair follicle because of their size and uniformity, than free CA. Besides, MPs present an additional advantage because they guarantee a continuous release of CA in the target for a prolonged period, allowing the treatment of folliculitis with a single dose until the MPs are removed from the hair follicle by its natural regeneration process or particle depletion of CA.
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